The Journal of oncology management : the official journal of the American College of Oncology Administrators最新文献_第2页

Where there is a will, there is a way: networks as a means of cancer control. 有志者事竟成:网络是癌症控制的一种手段。

The Journal of oncology management : the official journal of the American College of Oncology Administrators Pub Date : 2005-01-01

Martina N Strack, Barbara Poole, Frances Lasser, Simon Sutcliffe

引用次数: 0

Formulating strategies. 制定策略。

The Journal of oncology management : the official journal of the American College of Oncology Administrators Pub Date : 2005-01-01

Joseph M Spallina

引用次数: 0

Medical House Call Program: extending frail elderly medical care into the home. 医疗上门服务计划:将体弱多病的老人的医疗护理延伸到家中。

The Journal of oncology management : the official journal of the American College of Oncology Administrators Pub Date : 2005-01-01

J D Gammel

{"title":"Medical House Call Program: extending frail elderly medical care into the home.","authors":"J D Gammel","doi":"","DOIUrl":"","url":null,"abstract":"The current US healthcare system, focused mostly on acute and episodic care, has difficulty meeting the needs of ill, frail elderly and their families or other caregivers. Because of their low mobility and complex medical conditions, these \"oldest old\" patients and their families or caregivers must make frequent, difficult, and expensive trips to multiple physicians to receive care. The result is that the frail elderly most often receive delayed or crisis care rather than timely primary care. To address these and other needs, a coordinated approach to the care of the oldest old requires a new model that includes primary medical care in the home. This article discusses how the Medical House Call Program (MHCP) model can provide high-quality primary healthcare to the frail elderly at home, improve the continuity of care between the home and the hospital, provide support and education to families or caregivers, and provide linkage to a broad range of social and supportive services in the community. The MHCP model is one of a number of evolving for-profit and nonprofit approaches that seek to provide medical care in the home. This article also discusses how the MHCP model, working with oncology physicians and programs, can have similar benefits and applications for the growing number of elderly cancer patients and their families or caregivers.","PeriodicalId":80217,"journal":{"name":"The Journal of oncology management : the official journal of the American College of Oncology Administrators","volume":"14 2","pages":"39-46"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24898517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Integrating market data into your physician compensation plan. 将市场数据整合到你的医生薪酬计划中。

The Journal of oncology management : the official journal of the American College of Oncology Administrators Pub Date : 2005-01-01

Alex Hunter

引用次数: 0

Follow-up to the revised Cancer Program Standards 2004. 2004年修订的癌症项目标准的后续行动。

The Journal of oncology management : the official journal of the American College of Oncology Administrators Pub Date : 2005-01-01

Jeannie O'Leary

引用次数: 0

The daily moment: a stress reduction program for cancer center staff. 日常时刻:癌症中心工作人员的减压计划。

The Journal of oncology management : the official journal of the American College of Oncology Administrators Pub Date : 2005-01-01

Jeff Kendall, Cindy Waddington, Colleen Kendall

{"title":"The daily moment: a stress reduction program for cancer center staff.","authors":"Jeff Kendall, Cindy Waddington, Colleen Kendall","doi":"","DOIUrl":"","url":null,"abstract":"Keeping members of the oncology team from being overwhelmed by the stress of their jobs is a major concern at the Helen E. Graham Cancer Center and every cancer center around the country. The impact of stressors experienced as a result of caring for people is felt heavily not only by physicians and nurses, but also by each staff member in a cancer center. In addition to caregiving stressors, all cancer center staff experience corporation-style stressors such as staffing shortages, long hours, tight schedules, and limited resources. Therefore, the importance of finding innovative mechanisms for all staff to reduce their stress levels and develop stronger bonds with their coworkers is paramount. Given the stressors mentioned above, the Daily Moment program was developed. This involves staff gathering before morning rounds to listen to a staff member read an inspirational quote or an appropriate joke. The Daily Moment was developed with the following goals: (1) occur daily but not require much time, (2) energize staff for the day, (3) be effective for all levels of staffing, and (4) improve coworker relationships and interactions. Participation in the Daily Moment was voluntary. After 6 weeks of implementation, a survey was administered to all staff. Results indicated that all goals for the program were accomplished, and they demonstrated that innovative stress reduction programs may require little time and still generate positive influences on a cancer center staff. Finally, the simplicity of this program allows it to be instituted at any facility at any time with no cost.","PeriodicalId":80217,"journal":{"name":"The Journal of oncology management : the official journal of the American College of Oncology Administrators","volume":"14 3","pages":"68-71"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25301433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Modifications and revisions to program standards. 项目标准的修改和修订。

The Journal of oncology management : the official journal of the American College of Oncology Administrators Pub Date : 2005-01-01

Jeannie O'Leary

引用次数: 0

Comprehensive care plus creative architecture. 综合护理+创意建筑。

The Journal of oncology management : the official journal of the American College of Oncology Administrators Pub Date : 2005-01-01

James G Easter

引用次数: 0

IMRT: why is coding IMRT so hard? IMRT:为什么编码IMRT这么难?

The Journal of oncology management : the official journal of the American College of Oncology Administrators Pub Date : 2005-01-01

Deborah I Churchill

引用次数: 0

Phase I trial of an all-oral combination chemotherapy regimen: topotecan and capecitabine in solid tumor patients. 实体瘤患者全口服联合化疗方案的I期试验:拓扑替康和卡培他滨。

The Journal of oncology management : the official journal of the American College of Oncology Administrators Pub Date : 2005-01-01

John Nemunaitis, Ned Adams, Casey Cunningham, Neil Senzer, Sue Graham, David Barrera, John Nugent, Clinton Stewart

{"title":"Phase I trial of an all-oral combination chemotherapy regimen: topotecan and capecitabine in solid tumor patients.","authors":"John Nemunaitis, Ned Adams, Casey Cunningham, Neil Senzer, Sue Graham, David Barrera, John Nugent, Clinton Stewart","doi":"","DOIUrl":"","url":null,"abstract":"The objective of this phase I study was to investigate the safety of an all-oral combination chemotherapy regimen: topotecan and capecitabine. Topotecan was administered once a day for 5 consecutive days followed by 2 days of rest and was administered again for 5 consecutive days. The starting dose of topotecan was 0.5 mg/m2/d(-1). Capecitabine was administered concurrently at an oral dose of 1800 mg/m2/d(-1) divided twice daily for 14 concurrent consecutive days. Each cycle of treatment was 21 days. Topotecan pharmacokinetic studies were performed on day 1 of cycles 1 and 2. Nineteen patients with refractory cancer were treated. Dose-limiting toxicity (thrombocytopenia, diarrhea) was observed in 2 of 3 patients at a topotecan dose of 2.0 mg/m2/d(-1). A total of 10 patients were treated at the maximum-tolerated dose of topotecan (1.5 mg/m2/d(-1)) and only 1 treatment-related grade 3 nonhematologic toxic event was demonstrated; however, grade 3 hematologic toxicity was observed in 8 of 10 patients at the maximum-tolerated dose, although no correlated clinical sequela resulted. One patient achieved a partial response and 7 achieved stable disease for 4 months or longer. Measurement of plasma topotecan showed pharmacokinetics consistent with no alteration by capecitabine. In conclusion, we recommend further investigation of oral topotecan (1.5 mg/m2/d(-1)) on days 1 to 5 of each week for 2 weeks in combination with capecitabine (180 mg/m2 twice daily) on days 1 to 14 within a 21-day cycle.","PeriodicalId":80217,"journal":{"name":"The Journal of oncology management : the official journal of the American College of Oncology Administrators","volume":"14 3","pages":"77-90"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25299508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0